Remission in schizophrenia: Results from a 1-year study of long-acting risperidone injection
- 15 September 2005
- journal article
- clinical trial
- Published by Elsevier in Schizophrenia Research
- Vol. 77 (2-3) , 215-227
- https://doi.org/10.1016/j.schres.2005.03.006
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Remission in Schizophrenia: Proposed Criteria and Rationale for ConsensusAmerican Journal of Psychiatry, 2005
- Efficacy and safety of long-acting risperidone in stable patients with schizoaffective disorderJournal of Affective Disorders, 2004
- Patients with schizophrenia previously stabilized on conventional depot antipsychotics experience significant clinical improvements following treatment with long-acting risperidoneEuropean Psychiatry, 2004
- Treatment of Schizophrenia With Long-Acting Injectable RisperidoneThe Journal of Clinical Psychiatry, 2003
- Relapse Prevention in Schizophrenia With New-Generation Antipsychotics: A Systematic Review and Exploratory Meta-Analysis of Randomized, Controlled TrialsAmerican Journal of Psychiatry, 2003
- Comparative assessment of antipsychotic adherence by concentration monitoring, pill count and self-reportSchizophrenia Research, 2003
- A Multidose Study of Haloperidol Decanoate in the Maintenance Treatment of SchizophreniaAmerican Journal of Psychiatry, 2002
- Operational criteria and factors related to recovery from schizophreniaInternational Review of Psychiatry, 2002
- Recovery from schizophrenia: a challenge for the 21st centuryInternational Review of Psychiatry, 2002
- Saccadic Disinhibition in Patients With Acute and Remitted Schizophrenia and Their First-Degree Biological RelativesAmerican Journal of Psychiatry, 2001